NERV
Minerva Neurosciences
$2.21
−$0.02 (−0.9%)Oct 28, 2026
Key metrics
The numbers that frame NERV today
- Market cap
- $105.52M
- ROIC
- -478%
- Div yield
- 0%
- 52wk Low
- $2.12
- 52wk High
- $8.80
Growth
Revenue and earnings trend for NERV
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NERV
Is Minerva Neurosciences a good buy?
No. Minerva Neurosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Minerva Neurosciences is selling at a very high price.
What is the market capitalization of NERV?
Minerva Neurosciences's market capitalization is $105.52M.
What is the 52-week high for NERV stock?
The 52-week high for Minerva Neurosciences is $8.80. The current close of $2.21 is 74.9% below that high.
What is the 52-week low for NERV stock?
The 52-week low for Minerva Neurosciences is $2.12. The current close of $2.21 is 4.2% above that low.
Does NERV stock pay dividends?
Minerva Neurosciences does not currently show a dividend per share in the company data.